AKRO - Lowey Dannenberg P.C. is Investigating Akero Therapeutics Inc. (Akero) (NASDAQ: AKRO) for Potential Violations of the Federal Securities Laws and Encourages Investors with Losses to Contact the Firm | Benzinga
NEW YORK, May 30, 2024 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating Akero Therapeutics, Inc. ("Akero") (NASDAQ:AKRO) for potential violations of the federal securities laws.
If you suffered a loss in Akero securities, ...
AKRO) for Potential Violations of the Federal Securities Laws and Encourages Investors with Losses to Contact the Firm>Full story available on Benzinga.com